Charles Sidoti

Charles Sidoti is the Chief Technology Officer at Brixton Biosciences, where Charles aligns and implements technology and product development strategies. Charles also serves as the Head of Product Development at EyeCool Therapeutics and previously held roles in product development at Pulse Biosciences, SevenOaks Biosystems, Sage Product Development, MoMelan Technologies, and Fikst. Charles holds a Bachelor of Science and Master of Science in Mechanical Engineering from Northeastern University.